SCHEMBL14200239

SCHEMBL14200239

CC(C)(C)c1cc(-c2ccco2)cc(C(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 2/20 0.44
▸ POLB P06746 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ PRMT6 Q96LA8 1/20 0.41
▸ TOP1 P11387 1/20 0.40
▸ KEAP1 Q14145 1/20 0.40
▸ USP2 O75604 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ PTPN7 P35236 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14228224 0.85 PRMT6 (0.44) TAAR1POLBKDM4EMEN1ALDH1A1
SCHEMBL18161363 0.85 PRMT6 (0.50) TAAR1POLBKDM4EMEN1ALDH1A1
SCHEMBL1622533 0.82 TAAR1 (0.55) TAAR1POLBKDM4EMEN1ALDH1A1
SCHEMBL12459123 0.80 CHRNB1 (0.41) TAAR1POLBKDM4EMEN1ALDH1A1
SCHEMBL19662062 0.78 TAAR1 (0.58) TAAR1POLBKDM4EMEN1ALDH1A1
SCHEMBL26259873 0.77 TAAR1 (0.41) TAAR1POLBKDM4EMEN1ALDH1A1
SCHEMBL26259706 0.77 IMPDH2 (0.37) TAAR1POLBKDM4EMEN1ALDH1A1
SCHEMBL11064568 0.76 CA2 (0.55) POLBKDM4EMEN1ALDH1A1KMT2A
SCHEMBL22432020 0.73 PRMT6 (0.50) TAAR1POLBKDM4EMEN1ALDH1A1
SCHEMBL25795140 0.73 NOTUM (0.42) TAAR1KDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105209449-B Inhibitors of the kynurenine pathway 库拉德夫制药私人有限公司 2019-02-01 — — CN claimed
US-8778874-B2 Glycopeptide antibiotic monomer derivatives NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-07-15 — — US disclosed
US-20080097078-A1 Antibacterial activity against vancomycin-resistant bacteria SHIONOGI & CO., LTD. (JP) 2008-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080097078-A1 Antibacterial activity against vancomycin-resistant bacteria CSGALNACT1, MON2, NR2C2 TAAR1 1606/4885POLB 3767/4885KDM4E 4340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback